prosavin
Gene therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT00627588)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- GTP cyclohydrolase 1Supplementation
GCH1 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- prosavin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01856439 | Phase 1/Phase 2 (Phase 2) | May 1, 2011 | CHU Henri Mondor, Oxford BioMedica, University of Cambridge |
| NCT00627588 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2008 | CHU Henri Mondor, Oxford BioMedica |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CHU Henri Mondor | Academic/Hospital | 2 | 0 | 1 | 2008 |
| Oxford BioMedica | For profit | 2 | 2 | 1 | 2008 |
| University of Cambridge | Academic/Hospital | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1